International Journal of Legal Medicine

, Volume 132, Issue 2, pp 439–448 | Cite as

Serum lipid feature and potential biomarkers of lethal ventricular tachyarrhythmia (LVTA) induced by myocardial ion channel diseases: a rat model study

  • Jiayan Wu
  • Qian Wu
  • WenTao Dai
  • Jing Kong
  • Junyao Lv
  • Xiaojun Yu
  • Xingxing Wang
  • Dian Wang
Original Article


To determine the cause of death in myocardial ion channel diseases (MICD)-induced sudden cardiac death (SCD) cases is a difficulty in forensic identification practices. The majority of MICD-induced SCD cases would experience lethal ventricular tachyarrhythmia (LVTA) before deaths; thus, confirming the occurrence of LVTA in bodies can offer a key evidence to identify these cases. Several lipids in the myocardia were found disturbed after LVTA; yet, whether serum lipidome would be disrupted by LVTA is not clear. Therefore, we aimed to screen lipid feature and related diagnostic markers of LVTA in serum here. An aconitine-induced LVTA-SCD rat model was produced. Blood samples before LVTA and immediately after LVTA were retrieved and related serum specimens were used for ultra-performance liquid chromatography-mass spectrometry (UPLC-MS)-based lipidomics analyses. On the basis of the defined differential lipids, a lipid-related metabolic pathway network was constructed and potential biomarkers were screened. Twelve aconitine-induced LVTA rats were produced. Totally, 188 lipids in serum were disrupted during the LVTA-SCD process, which belong to 11 lipid classes. Most of the differential lipids were correlated, suggesting that they were interacted and that the changes were holistic during LVTA process. Ten lipid pathways were activated during LVTA process; the main lipid classes involved in these pathways were ceramide, sphingomyelin, phosphatidylcholine, phosphatidylethanolamine, and phosphatidylserine. Phosphatidylcholine O-40:4, sphingomyelin d46:5, and phosphatidylethanolamine 40:4 were tested as potential diagnostic markers of LVTA-SCD event in serum. The current results indicate a substantial change in serum lipidome after LVTA-SCD; lipidomics holds promise to identify MICD-induced SCDs in forensic practices.


Myocardial ion channel diseases Sudden cardiac death Lethal ventricular tachyarrhythmia Lipidomics Diagnostic markers 



This work was supported by grants from the Natural Science Foundation (2015A408119346049), the Science and Technology Innovation project (2013KJCX0076) of Guangdong Province, and the Natural Science Foundation of Shanghai (15ZR1430300), China.

Compliance with ethical standards

This study was approved by the Medical Animal Care and Welfare Committee at Shantou University Medical College (number of authorization: SUMC 2014-157). All procedures were carried out in accordance with the Guide for Care and Use of Laboratory Animals of our College.

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

414_2017_1710_MOESM1_ESM.docx (15.4 mb)
ESM 1 (DOCX 15749 kb)


  1. 1.
    Marsman RF, Tan HL, Bezzina CR (2014) Genetics of sudden cardiac death caused by ventricular arrhythmias. Nat Rev Cardiol 11(2):96–111. CrossRefPubMedGoogle Scholar
  2. 2.
    Winkel BG, Holst AG, Theilade J, Kristensen IB, Thomsen JL, Ottesen GL, Bundgaard H, Svendsen JH, Haunso S, Tfelt-Hansen J (2011) Nationwide study of sudden cardiac death in persons aged 1-35 years. Eur Heart J 32(8):983–990. CrossRefPubMedGoogle Scholar
  3. 3.
    Zipes DP, Wellens HJ (1998) Sudden cardiac death. Circulation 98(21):2334–2351CrossRefPubMedGoogle Scholar
  4. 4.
    Ifteni P, Barabas B, Gavris C, Moga M, Burtea V, Dracea L (2017) Sudden cardiac death: autopsy findings in 7200 cases between 2001 and 2015. Am J Forensic Med Pathol 38(1):49–53. PubMedGoogle Scholar
  5. 5.
    Basso C, Carturan E, Pilichou K, Rizzo S, Corrado D, Thiene G (2010) Sudden cardiac death with normal heart: molecular autopsy. Cardiovasc Pathol 19(6):321–325. CrossRefPubMedGoogle Scholar
  6. 6.
    Corrado D, Basso C, Thiene G (2001) Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res 50(2):399–408CrossRefPubMedGoogle Scholar
  7. 7.
    Brion M, Sobrino B, Martinez M, Blanco-Verea A, Carracedo A (2015) Massive parallel sequencing applied to the molecular autopsy in sudden cardiac death in the young. Forensic Sci Int Genet 18:160–170. CrossRefPubMedGoogle Scholar
  8. 8.
    Chopra N, Knollmann BC (2011) Genetics of sudden cardiac death syndromes. Curr Opin Cardiol 26(3):196–203. CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wang X, Wang D, Yu X, Zhang G, Wu J, Zhu G, Su R, Lv J (2016) Non-targeted metabolomics identified a common metabolic signature of lethal ventricular tachyarrhythmia (LVTA) in two rat models. Mol BioSyst 12(7):2213–2223. CrossRefPubMedGoogle Scholar
  10. 10.
    Curtis MJ, Walker MJ (1988) Quantification of arrhythmias using scoring systems: an examination of seven scores in an in vivo model of regional myocardial ischaemia. Cardiovasc Res 22(9):656–665CrossRefPubMedGoogle Scholar
  11. 11.
    Gibellini F, Smith TK (2010) The Kennedy pathway—de novo synthesis of phosphatidylethanolamine and phosphatidylcholine. IUBMB Life 62(6):414–428. CrossRefPubMedGoogle Scholar
  12. 12.
    An Nguyen SAR, Zhang Q, Michael JO Wakelam Using lipidomics analysis to determine signalling and metabolic changes in cellsGoogle Scholar
  13. 13.
    Bach D, Epand RF, Epand RM, Wachtel E (2008) Interaction of 7-ketocholesterol with two major components of the inner leaflet of the plasma membrane: phosphatidylethanolamine and phosphatidylserine. Biochemistry 47(9):3004–3012. CrossRefPubMedGoogle Scholar
  14. 14.
    Sun GB, Sun H, Meng XB, Hu J, Zhang Q, Liu B, Wang M, HB X, Sun XB (2014) Aconitine-induced Ca2+ overload causes arrhythmia and triggers apoptosis through p38 MAPK signaling pathway in rats. Toxicol Appl Pharmacol 279(1):8–22. CrossRefPubMedGoogle Scholar
  15. 15.
    Zimmer T, Surber R (2008) SCN5A channelopathies—an update on mutations and mechanisms. Prog Biophys Mol Biol 98(2–3):120–136. CrossRefPubMedGoogle Scholar
  16. 16.
    Liu N, Denegri M, Dun W, Boncompagni S, Lodola F, Protasi F, Napolitano C, Boyden PA, Priori SG (2013) Abnormal propagation of calcium waves and ultrastructural remodeling in recessive catecholaminergic polymorphic ventricular tachycardia. Circ Res 113(2):142–152. CrossRefPubMedGoogle Scholar
  17. 17.
    Bezzina CR, Lahrouchi N, Priori SG (2015) Genetics of sudden cardiac death. Circ Res 116(12):1919–1936. CrossRefPubMedGoogle Scholar
  18. 18.
    Guarino MP, Santos AI, Mota-Carmo M, Costa PF (2013) Effects of anaesthesia on insulin sensitivity and metabolic parameters in Wistar rats. In Vivo (Athens, Greece) 27(1):127–132Google Scholar
  19. 19.
    Das G, Vernunft A, Gors S, Kanitz E, Weitzel JM, Brussow KP, Metges CC (2016) Acute effects of general anesthesia with propofol, pentobarbital or isoflurane plus propofol on plasma metabolites and hormones in adult pigs. J Anim Sci 94(12):5182–5191. CrossRefPubMedGoogle Scholar
  20. 20.
    Hirvonen J, Kortelainen ML, Huttunen P (1997) Pulmonary and serum surfactant phospholipids and serum catecholamines in strangulation. An experimental study on rats. Forensic Sci Int 90(1–2):17–24CrossRefPubMedGoogle Scholar
  21. 21.
    Wang Q, Ishikawa T, Michiue T, Zhu BL, Guan DW, Maeda H (2012) Intrapulmonary aquaporin-5 expression as a possible biomarker for discriminating smothering and choking from sudden cardiac death: a pilot study. Forensic Sci Int 220(1–3):154–157. CrossRefPubMedGoogle Scholar
  22. 22.
    Verkleij AJ, Leunissen-Bijvelt J, de Kruijff B, Hope M, Cullis PR (1984) Non-bilayer structures in membrane fusion. CIBA Found Symp 103:45–59PubMedGoogle Scholar
  23. 23.
    Wang Z, Klipfell E, Bennett BJ, Koeth R, Levison BS, Dugar B, Feldstein AE, Britt EB, Fu X, Chung YM, Wu Y, Schauer P, Smith JD, Allayee H, Tang WH, DiDonato JA, Lusis AJ, Hazen SL (2011) Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472(7341):57–63. CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Stegemann C, Pechlaner R, Willeit P, Langley SR, Mangino M, Mayr U, Menni C, Moayyeri A, Santer P, Rungger G, Spector TD, Willeit J, Kiechl S, Mayr M (2014) Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study. Circulation 129(18):1821–1831. CrossRefPubMedGoogle Scholar
  25. 25.
    Hatch GM, O K CPC (1989) Regulation of phosphatidylcholine metabolism in mammalian hearts. Biochem Cell Biol 67(2–3):67–77CrossRefPubMedGoogle Scholar
  26. 26.
    Chen X, Sun A, Zou Y, Ge J, Lazar JM, Jiang XC (2011) Impact of sphingomyelin levels on coronary heart disease and left ventricular systolic function in humans. Nutr Metab 8(1):25. CrossRefGoogle Scholar
  27. 27.
    Chapman H, Ramstrom C, Korhonen L, Laine M, Wann KT, Lindholm D, Pasternack M, Tornquist K (2005) Downregulation of the HERG (KCNH2) K(+) channel by ceramide: evidence for ubiquitin-mediated lysosomal degradation. J Cell Sci 118(Pt 22):5325–5334. CrossRefPubMedGoogle Scholar
  28. 28.
    Park TS, Hu Y, Noh HL, Drosatos K, Okajima K, Buchanan J, Tuinei J, Homma S, Jiang XC, Abel ED, Goldberg IJ (2008) Ceramide is a cardiotoxin in lipotoxic cardiomyopathy. J Lipid Res 49(10):2101–2112. CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Zhou YT, Grayburn P, Karim A, Shimabukuro M, Higa M, Baetens D, Orci L, Unger RH (2000) Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A 97(4):1784–1789CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Chugh SS, Kelly KL, Titus JL (2000) Sudden cardiac death with apparently normal heart. Circulation 102(6):649–654CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany 2017

Authors and Affiliations

  • Jiayan Wu
    • 1
  • Qian Wu
    • 2
  • WenTao Dai
    • 2
  • Jing Kong
    • 1
  • Junyao Lv
    • 1
  • Xiaojun Yu
    • 1
  • Xingxing Wang
    • 3
  • Dian Wang
    • 1
  1. 1.Department of Forensic MedicineShantou University Medical CollegeShantouChina
  2. 2.Shanghai Center for Bioinformation TechnologyShanghaiChina
  3. 3.2nd Affiliated HospitalShantou University Medical CollegeShantouChina

Personalised recommendations